Literature DB >> 19132767

Translational pain research: evaluating analgesic effect in experimental visceral pain models.

Anne Estrup Olesen1, Trine Andresen, Lona Louring Christrup, Richard N Upton.   

Abstract

Deep visceral pain is frequent and presents major challenges in pain management, since its pathophysiology is still poorly understood. One way to optimize treatment of visceral pain is to improve knowledge of the mechanisms behind the pain and the mode of action of analgesic substances. This can be achieved through standardized experimental human pain models. Experimental pain models in healthy volunteers are advantageous for evaluation of analgesic action, as this is often difficult to assess in the clinic because of confounding factors such as sedation, nausea and general malaise. These pain models facilitate minimizing the gap between knowledge gained in animal and human clinical studies. Combining experimental pain studies and pharmacokinetic studies can improve understanding of the pharmacokinetic-pharmacodynamic relationship of analgesics and, thus, provide valuable insight into optimal clinical treatment of visceral pain. To improve treatment of visceral pain, it is important to study the underlying mechanisms of pain and the action of analgesics used for its treatment. An experimental pain model activates different modalities and can be used to investigate the mechanism of action of different analgesics in detail. In combination with pharmacokinetic studies and objective assessment such as electroencephalography, new information regarding a given drug substance and its effects can be obtained. Results from experimental human visceral pain research can bridge the gap in knowledge between animal studies and clinical condition in patients suffering from visceral pain, and thus constitute the missing link in translational pain research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19132767      PMCID: PMC2653309          DOI: 10.3748/wjg.15.177

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  Opioids and the gut: pharmacology and current clinical experience.

Authors:  H U De Schepper; F Cremonini; M-I Park; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2004-08       Impact factor: 3.598

Review 2.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

3.  Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation.

Authors:  M B Burton; G F Gebhart
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

4.  The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.

Authors:  M Delvaux; D Louvel; E Lagier; B Scherrer; J L Abitbol; J Frexinos
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

5.  The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep.

Authors:  R N Upton; G L Ludbrook; E C Gray; C Grant
Journal:  Anesthesiology       Date:  1997-06       Impact factor: 7.892

6.  Pharmacodynamics and pharmacokinetics of high-dose oxycodone infusion during and after coronary artery bypass grafting.

Authors:  Reino Pöyhiä; Markku Hynynen; Timo Seppälä; Risto O Roine; Kalervo Verkkala; Klaus T Olkkola
Journal:  J Cardiothorac Vasc Anesth       Date:  2004-12       Impact factor: 2.628

7.  The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.

Authors:  Fraser B Ross; Maree T Smith
Journal:  Pain       Date:  1997-11       Impact factor: 6.961

8.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.

Authors:  E H Cox; T Kerbusch; P H Van der Graaf; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

9.  Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans.

Authors:  A B Gorelick; S S Koshy; F G Hooper; T C Bennett; W D Chey; W L Hasler
Journal:  Am J Physiol       Date:  1998-09

10.  Imipramine decreases oesophageal pain perception in human male volunteers.

Authors:  P L Peghini; P O Katz; D O Castell
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more
  4 in total

1.  New technologies in gastrointestinal research.

Authors:  Asbjørn Mohr Drewes; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

2.  A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model.

Authors:  K Prabhavathi; U Shobha Jagdish Chandra; Radhika Soanker; P Usha Rani
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

Review 3.  Neuroimaging in the Understanding of Acupuncture Analgesia: A Review of Acupuncture Neuroimaging Study Based on Experimental Pain Models.

Authors:  Ma Peihong; Qu Yuzhu; Yin Tao; He Zhaoxuan; Cheng Shirui; Teng Yuke; Xie Kunnan; Li Shenghong; Sun Ruirui; Zeng Fang
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

4.  A randomized, double-blind, placebo-controlled, cross-over study to evaluate analgesic activity of Terminalia chebula in healthy human volunteers using a mechanical pain model.

Authors:  Venkata Kishan Pokuri; Chiranjeevi Uday Kumar; Usharani Pingali
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.